Filing Details
- Accession Number:
- 0001127602-17-010359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-06 10:11:45
- Reporting Period:
- 2017-03-03
- Filing Date:
- 2017-03-06
- Accepted Time:
- 2017-03-06 10:11:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1680593 | Sybrand Pretorius | C/O Parexel International Corporation 195 West Street Waltham MA 02451 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-03 | 8,050 | $12.55 | 9,950 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-03 | 8,050 | $65.12 | 1,900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-03 | 8,050 | $0.00 | 8,050 | $12.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-09-09 | No | 4 | M | Direct |
Footnotes
- These shares were sold in multiple transactions at prices ranging from $65.03 to $65.21. The price reported in this column reflects a weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Fully exercisable.
Billionaire Hedge Funds
